Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides
US7915002B2 · kind B2 · utility
13Cited by
0References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 18, 2007 |
| Grant date | Mar 29, 2011 |
| Priority date | — |
| Expiry date | Jul 18, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/325
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed is a method for controlling the therapeutic treatment of a patient suffering from cardiac insufficiency. In said method, it is determined how the concentration of at least one of the vasoactive peptides adrenomedullin (ADM), endothelin-1 (ET-1), and/or vasopressin (AVP) changes in the patient's blood after beginning the therapy, and the therapeutic measures are considered to be unsatisfactory and are modified in case said concentration does not decrease at all or not enough in relation to a threshold value for the respective vasoactive peptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.